Predicting the therapeutic role and potential mechanisms of Indole-3-acetic acid in diminished ovarian reserve based on network pharmacology and molecular docking
article
OA: gold
CC0
Abstract
BACKGROUND: Indole-3-acetic acid (IAA), an indole analog produced by intestinal microorganisms metabolizing tryptophan, has anti-inflammatory and antioxidant properties and thus has potential applications in ovarian protection, although the exact mechanism is unknown. The present study preliminarily investigated the pharmacological mechanism of IAA in alleviating diminished ovarian reserve (DOR) by network pharmacology and molecular docking. METHODS: Relevant target proteins of IAA were searched in SwissTargetPrediction, PharmMapper, TargetNet, BATMAN-TCM, and SuperPred databases. The potential targets of DOR were obtained from GeneCards, DisGenet, OMIM, and Drugbank databases. Both common targets were then imported into the String website to construct a PPI network, and these targets were analyzed for GO and KEGG enrichment. Finally, we utilized molecular docking to validate the possible binding conformations between IAA and the candidate targets. We used in vitro experiments to preliminarily investigate the effects of IAA on DOR. RESULTS: We obtained 88 potential targets for IAA and DOR interaction. We received 16 pivotal targets by constructed protein interaction screening. KEGG enrichment analysis mainly included the AGE-RAGE signaling pathway, IL-17 signaling pathway, Chemical carcinogenesis-reactive oxygen species in diabetic complications, etc. GO functional analysis showed that IAA treatment of DOR may involve biological processes such as response to external stimuli, hypoxia, gene expression, and regulation of enzyme activity. Molecular docking and in vitro experiments further revealed the potential effects of IAA on MMP2, TNF-α, AKT1, HSP90AA1, and NF-κ B. CONCLUSION: We preliminarily revealed the potential protective effects of IAA against DOR through multiple targets and pathways, which provides a new research strategy for the molecular mechanism of IAA to alleviate DOR in the future. However, further studies need to demonstrate whether IAA can be used as a compound to prevent and treat DOR.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (73)
- Determination of tryptophan and its indole metabolites in follicular fluid of women with diminished ovarian reserve via openalex
- Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals via openalex
- doi:10.1007/s10815-019-01446-5 via openalex
- doi:10.1093/nar/gkx1037 via openalex
- doi:10.1093/nar/gkz382 via openalex
- doi:10.1093/humrep/det383 via openalex
- doi:10.1016/j.jri.2022.103628 via openalex
- doi:10.1016/j.yexcr.2021.113002 via openalex
- doi:10.3389/fimmu.2022.762580 via openalex
- doi:10.1210/jcem.85.1.6242 via openalex
- doi:10.1093/nar/gkab294 via openalex
- doi:10.2741/949 via openalex
- doi:10.1093/nar/gkad926 via openalex
- doi:10.1093/humrep/dey006 via openalex
- doi:10.1016/j.freeradbiomed.2024.05.048 via openalex
- doi:10.1186/s13048-023-01293-0 via openalex
- doi:10.1002/rmb2.12292 via openalex
- doi:10.1002/jcp.30468 via openalex
- doi:10.1262/jrd.2021-132 via openalex
- doi:10.1186/s12958-023-01082-w via openalex
- doi:10.1016/j.lfs.2023.122182 via openalex
- doi:10.1093/nar/gku1003 via openalex
- doi:10.1016/s0378-1119(02)01201-5 via openalex
- doi:10.1007/s10822-016-9915-2 via openalex
- doi:10.1063/5.0018516 via openalex
- doi:10.1007/s11655-021-3353-2 via openalex
- doi:10.3390/ijms22189838 via openalex
- doi:10.1016/j.bbrc.2023.04.113 via openalex
- doi:10.1093/nar/gkac194 via openalex
- doi:10.1016/s0006-291x(02)00431-x via openalex
- doi:10.12659/msm.910410 via openalex
- doi:10.1016/j.gene.2015.06.018 via openalex
- doi:10.1016/j.fertnstert.2018.01.030 via openalex
- doi:10.1111/rda.12736 via openalex
- doi:10.1093/nar/gkx374 via openalex
- doi:10.1371/journal.pone.0015770 via openalex
- W3092054218 via openalex
- doi:10.1155/2017/8639485 via openalex
- doi:10.1093/nar/gkac1052 via openalex
- doi:10.1007/s10815-007-9156-3 via openalex
- doi:10.1016/j.bbamem.2018.11.009 via openalex
- doi:10.1093/nar/gkac297 via openalex
- W4206224235 via openalex
- doi:10.3390/nu11092062 via openalex
- W4207074834 via openalex
- doi:10.1095/biolreprod.109.077925 via openalex
- doi:10.4238/2015.december.21.1 via openalex
- doi:10.1007/s004410050986 via openalex
- doi:10.3168/jds.2023-24007 via openalex
- doi:10.1016/j.jep.2023.117023 via openalex
- doi:10.1016/j.jep.2023.116306 via openalex
- doi:10.3389/fimmu.2023.1293048 via openalex
- doi:10.1016/0012-1606(85)90137-x via openalex
- doi:10.1186/s13148-023-01487-9 via openalex
- doi:10.18632/oncotarget.21731 via openalex
- doi:10.3390/ijms21051579 via openalex
- doi:10.1038/s41577-022-00792-3 via openalex
- doi:10.1210/er.2002-0005 via openalex
- doi:10.1093/nar/gku1205 via openalex
- doi:10.3390/ijms24119205 via openalex
- doi:10.1038/s41598-020-79488-4 via openalex
- doi:10.1093/nar/gkz1021 via openalex
- doi:10.1016/j.jri.2024.104253 via openalex
- doi:10.1159/000535508 via openalex
- doi:10.1530/rep-23-0411 via openalex
- doi:10.3389/fendo.2023.1172481 via openalex
- doi:10.7717/peerj.9812 via openalex
- doi:10.1093/nar/gkac956 via openalex
- doi:10.1007/s43032-024-01467-1 via openalex
- doi:10.1093/database/baq020 via openalex
- doi:10.1530/rep-21-0022 via openalex
- doi:10.1016/j.jep.2024.117944 via openalex
- doi:10.1007/s10815-014-0257-5 via openalex
Source provenance
- openalex
- last seen: 2026-05-14T06:17:32.558309+00:00
License: CC0
· commercial use OK